Français
ItalianoBond Lilly & Co 7.125% ( US532457AM04 ) in USD
| Issuer | Lilly & Co |
| Market price | 100.743 % ▼ |
| Country |  United States
|
| ISIN code |
 US532457AM04 ( in USD )
|
| Interest rate | 7.125% per year ( payment 2 times a year) |
| Maturity | 31/05/2025 - Bond has expired |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 1 000 USD |
| Total amount | 229 692 000 USD |
| Cusip | 532457AM0 |
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
| Moody's rating | Aa3 ( High grade - Investment-grade ) |
| Detailed description |
Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, Indiana, that researches, develops, manufactures, and markets pharmaceutical products, including medicines for diabetes, oncology, immunology, and neuroscience. Eli Lilly & Co. issued a USD 229,692,000 bond (ISIN: US532457AM04, CUSIP: 532457AM0) maturing May 31, 2025, currently trading at 101.783% of par value with a 7.125% coupon rate, paying semi-annually, and rated A+ by S&P and A1 by Moody's, with a minimum purchase size of 1,000. |